Status:
WITHDRAWN
Retinal Metabolic Imaging in a Diverse Population
Lead Sponsor:
Optina Diagnostics Inc.
Collaborating Sponsors:
Sunnybrook Health Sciences Centre
Conditions:
Technical Capabilities of the Device
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research project aims to evaluate use in a clinical context of a novel imaging instrument, the Metabolic Hyperspectral retina Camera (MHRC) from Optina Diagnostics. This camera enables the acquis...
Detailed Description
Hyperspectral retinal imaging results from several consecutive images taken while the filter scans a wide spectral range to obtain one spectrum for each image pixel. The combination of imaging and spe...
Eligibility Criteria
Inclusion
- 18 years old and up with vision in at least one eye.
Exclusion
- Inadequate pupil dilation (\< 6mm diameter) or contraindicated
- Deficient visual fixation
- Refractive error outside the -9 to +9 range
- Media opacities or intraocular bleeding preventing retinal imaging
Key Trial Info
Start Date :
July 5 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 26 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03442816
Start Date
July 5 2017
End Date
September 26 2020
Last Update
March 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5